These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 28627594)
1. MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1. Zhao Y; Zhang S; Zhang Y Mol Med Rep; 2017 Aug; 16(2):2191-2198. PubMed ID: 28627594 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase. Lei T; Zhu Y; Jiang C; Wang Y; Fu J; Fan Z; Qin H Mol Med Rep; 2016 Aug; 14(2):1255-62. PubMed ID: 27277534 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinoma. Cheng L; Zhou R; Chen M; Feng L; Li H Mol Med Rep; 2017 Aug; 16(2):2217-2224. PubMed ID: 28656254 [TBL] [Abstract][Full Text] [Related]
4. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Zhang H; Yang X; Xu Y; Li H Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345272 [TBL] [Abstract][Full Text] [Related]
5. MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway. Yan H; Li J; Ying Y; Xie H; Chen H; Xu X; Zheng X Cell Cycle; 2018; 17(24):2790-2801. PubMed ID: 30526300 [TBL] [Abstract][Full Text] [Related]
6. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer. Xu Y; Hu J; Zhang C; Liu Y Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044 [TBL] [Abstract][Full Text] [Related]
8. miR-29a inhibits human retinoblastoma progression by targeting STAT3. Liu S; Zhang X; Hu C; Wang Y; Xu C Oncol Rep; 2018 Feb; 39(2):739-746. PubMed ID: 29251322 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma. Han X; Wang X; Zhao B; Chen G; Sheng Y; Wang W; Teng M Mol Med Rep; 2017 Aug; 16(2):2241-2246. PubMed ID: 28627639 [TBL] [Abstract][Full Text] [Related]
10. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. Qiu T; Zhou X; Wang J; Du Y; Xu J; Huang Z; Zhu W; Shu Y; Liu P FEBS Lett; 2014 Apr; 588(7):1168-77. PubMed ID: 24613927 [TBL] [Abstract][Full Text] [Related]
11. The down-regulation of microRNA-137 contributes to the up-regulation of retinoblastoma cell proliferation and invasion by regulating COX-2/PGE2 signaling. Zhang J; He J; Zhang L Biomed Pharmacother; 2018 Oct; 106():35-42. PubMed ID: 29945115 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1. Liu Y; Liu J; Wang L; Yang X; Liu X Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1. Wang L; Wang L; Li L; Zhang H; Lyu X Mol Med Rep; 2019 Oct; 20(4):3440-3447. PubMed ID: 31432120 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3. Wang Y; Li Y; Wu B; Shi C; Li C Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6. Li J; You X Oncol Rep; 2018 Sep; 40(3):1777-1786. PubMed ID: 30015924 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway. Wu S; Ai N; Liu Q; Zhang J Oncol Rep; 2018 May; 39(5):2402-2412. PubMed ID: 29517104 [TBL] [Abstract][Full Text] [Related]
17. MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression. Li X; Yang L; Shuai T; Piao T; Wang R Biomed Pharmacother; 2016 Aug; 82():247-55. PubMed ID: 27470361 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6. Wang J; Wang X; Li Z; Liu H; Teng Y FEBS J; 2014 Mar; 281(5):1355-1365. PubMed ID: 24289859 [TBL] [Abstract][Full Text] [Related]
19. MiR‑500a‑5p promotes glioblastoma cell proliferation, migration and invasion by targeting chromodomain helicase DNA binding protein 5. Liu Z; Su D; Qi X; Ma J Mol Med Rep; 2018 Sep; 18(3):2689-2696. PubMed ID: 30015879 [TBL] [Abstract][Full Text] [Related]
20. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]